A. Gillespie-Twardy

Tumor Outcomes for ROMAN: Phase 3 Trial of Avasopasem Manganese (GC4419) for Severe Oral Mucositis (SOM) in Patients Receiving Chemoradiotherapy (CRT) for Locally Advanced Head and Neck Cancer (LAHNC)

V. King, J. Holmlund, N. Dunlap, 2022, International Journal of Radiation Oncology*Biology*Physics.